Mead Dana G Jr.
Transaction: 06/05/2026
BUY
Change
+40,000
Price
Not reported
Filing
06/09/2026
Type
BUY
Pulmonx Corporation
LUNG • Medical - Devices
$2.21
▼ -0.05 (-2.21%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$93.23M
Growth
12.7%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 13.5%Healthy liquidity · 5.07Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.21
Change-2.21%
Shares Out42.18M
Market Cap$93.23M
Enterprise Value$93.60M
52W Range1.13 - 2.89
Beta0.31
P/E-1.94
P/S1.07
P/B2.38
P/FCF-3.04
EV/Sales1.07
Price$2.21
Change-2.21%
Shares Out42.18M
Market Cap$93.23M
Enterprise Value$93.60M
52W Range1.13 - 2.89
Beta0.31
P/E-1.94
P/S1.07
P/B2.38
P/FCF-3.04
EV/Sales1.07
EV/EBITDA-2.12
EV/FCF-3.05
Earnings Yield-51.61%
FCF Yield-32.90%
Dividend Yield0.00%
Gross Margin74.19%
Oper. Margin-59.30%
Profit Margin-59.67%
Debt/Eq1.04
Current Ratio5.07
Quick Ratio4.28
Revenue 5Y12.65%
Target$10.00
Target Upside352.49%
Target Median$9.75
Target Range2.50 - 20.00
Volume545.62K
Avg Volume464.44K
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
54
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Positive revenue growth · 13.5%Healthy liquidity · 5.07Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
67/100
Neutral
Bullish
4
Hold
4
Bearish
1
Price Target
2026-08-06
Low
$2.50
Mean
$10.00
Median
$9.75
High
$20.00
Insider Transactions
Recent executive and insider activity
Sullivan Tiffany
Transaction: 06/05/2026
BUY
Change
+40,000
Price
Not reported
Filing
06/09/2026
Type
BUY
Melenikiotou Georgia
Transaction: 06/05/2026
BUY
Change
+40,000
Price
Not reported
Filing
06/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mead Dana G Jr. | BUY | +40,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Sullivan Tiffany | BUY | +40,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Melenikiotou Georgia | BUY | +40,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Florin Daniel P | BUY | +40,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Ferrari Richard | BUY | +40,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Burns Thomas William | BUY | +40,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Lehman David Aaron | SELL | -4,051 | $1.43 | 03/02/2026 | 03/04/2026 |
| Rose Geoffrey Beran | SELL | -2,911 | $1.43 | 03/02/2026 | 03/04/2026 |
| French Glendon E. III | SELL | -58,368 | $1.43 | 03/02/2026 | 03/04/2026 |
| Radhakrishnan Srikanth | SELL | -4,198 | $1.43 | 03/02/2026 | 03/04/2026 |
| Radhakrishnan Srikanth | OTHER | +1,383 | $1.40 | 12/03/2025 | 12/10/2025 |
| Radhakrishnan Srikanth | OTHER | 0 | Not reported | 12/03/2025 | 12/10/2025 |
| Florin Daniel P | SELL | -23,321 | $1.99 | 12/08/2025 | 12/09/2025 |
| Lehman David Aaron | SELL | -3,401 | $1.57 | 12/01/2025 | 12/03/2025 |
| Sung Derrick | BUY | +400,000 | Not reported | 12/01/2025 | 12/03/2025 |
| Sung Derrick | BUY | +1,200,000 | Not reported | 12/01/2025 | 12/03/2025 |
| Rose Geoffrey Beran | SELL | -2,379 | $1.57 | 12/01/2025 | 12/03/2025 |
| French Glendon E. III | BUY | +800,000 | Not reported | 12/01/2025 | 12/03/2025 |
| French Glendon E. III | SELL | -6,281 | $1.57 | 12/01/2025 | 12/03/2025 |
| Sung Derrick | OTHER | 0 | Not reported | 11/03/2025 | 11/10/2025 |